| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5618765 | Molecular Metabolism | 2017 | 7 Pages |
Abstract
We herein show that a recently developed unimolecular peptide triagonist is equally efficient in both sexes, suggesting that this polypharmaceutical strategy might be a relevant alternative to bariatric surgery for the treatment of obesity and related metabolic disorders.
Related Topics
Life Sciences
Neuroscience
Endocrine and Autonomic Systems
Authors
Sigrid Jall, Stephan Sachs, Christoffer Clemmensen, Brian Finan, Frauke Neff, Richard D. DiMarchi, Matthias H. Tschöp, Timo D. Müller, Susanna M. Hofmann,